Precision IO Group Inc.
About Precision IO Group Inc.
Precision IO Group Inc. is a private interventional oncology company formed through the combination of Quantum Surgical and NeuWave Medical. It provides minimally invasive cancer treatments via subsidiaries specializing in robotics, AI, and tumor ablation, including the Epione robotic ablation platform and microwave ablation systems. The company focuses on remote-enabled interventions to expand access to percutaneous procedures. Headquartered in Miami, Florida, it operates in the Healthcare & Life Sciences sector.
- 🔗 Precision IO Group Inc. Valuation & Funding History | Caplight
- 🔗 Precision IO Group to Present Epione® Robotic Platform and Remote Intervention Program at Society of Robotic Surgery Annual Meeting
- 🔗 Quantum Surgical Acquires NeuWave Medical: Precision IO and Robotic Ablation | MedDeviceGuide
- 🔗 Precision IO Group Precision Cancer Care, Reimagined.
- 🔗 Quantum Surgical
Investors
Not disclosed in the source filing. Form D filings do not list investors — StreetZero surfaces them from news where available.
Key highlights
- Formed via combination of Quantum Surgical and NeuWave Medical as parent company.
- Develops Epione robotic platform for minimally invasive tumor ablation.
- Investing in remote interventions for trajectory planning and post-treatment assessment.
- Led by CEO Kurt Azarbarzin, former executive at SurgiQuest and Verb Surgical.
- Operates subsidiaries focused on microwave ablation and robotic systems.
Tech stack
Ask StreetZero about Precision IO Group Inc.
Put our AI to work on this deal.
Similar companies
Other Other Technology deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account